Target Global Acquisition I Corp

PINK:TGAA USA Shell Companies
Market Cap
$82.48 Million
Market Cap Rank
#25352 Global
#8662 in USA
Share Price
$11.57
Change (1 day)
+0.00%
52-Week Range
$11.57 - $11.57
All Time High
$11.57
About

Target Global Acquisition I Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to focus on companies operating in the consumer internet, mobility, and financial technology sectors. The company was incorporated in 2021 and… Read more

Target Global Acquisition I Corp (TGAA) - Net Assets

Latest net assets as of March 2025: $15.63 Million USD

Based on the latest financial reports, Target Global Acquisition I Corp (TGAA) has net assets worth $15.63 Million USD as of March 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($20.74 Million) and total liabilities ($5.11 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $15.63 Million
% of Total Assets 75.38%
Annual Growth Rate -58.09%
5-Year Change N/A
10-Year Change N/A
Growth Volatility 35.08

Target Global Acquisition I Corp - Net Assets Trend (2021–2024)

This chart illustrates how Target Global Acquisition I Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Target Global Acquisition I Corp (2021–2024)

The table below shows the annual net assets of Target Global Acquisition I Corp from 2021 to 2024.

Year Net Assets Change
2024-12-31 $15.63 Million -57.27%
2023-12-31 $36.59 Million -82.94%
2022-12-31 $214.43 Million +0.92%
2021-12-31 $212.47 Million --

Equity Component Analysis

This analysis shows how different components contribute to Target Global Acquisition I Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 162339300.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Common Stock $20.74 Million 132.63%
Total Equity $15.63 Million 100.00%

Target Global Acquisition I Corp Competitors by Market Cap

The table below lists competitors of Target Global Acquisition I Corp ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Target Global Acquisition I Corp's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 36,588,641 to 15,634,675, a change of -20,953,966 (-57.3%).
  • Net loss of 4,912,112 reduced equity.
  • Share repurchases of 24,603,697 reduced equity.
  • Other factors increased equity by 8,561,843.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income $-4.91 Million -31.42%
Share Repurchases $24.60 Million -157.37%
Other Changes $8.56 Million +54.76%
Total Change $- -57.27%

Book Value vs Market Value Analysis

This analysis compares Target Global Acquisition I Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 2.15x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has increased from 1.46x to 2.15x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2021-12-31 $7.91 $11.57 x
2022-12-31 $7.98 $11.57 x
2023-12-31 $3.93 $11.57 x
2024-12-31 $5.37 $11.57 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Target Global Acquisition I Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -31.42%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 0.00%
  • • Asset Turnover: 0.00x
  • • Equity Multiplier: 1.33x
  • Recent ROE (-31.42%) is below the historical average (-5.21%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2021 -0.05% 0.00% 0.00x 1.04x $-21.36 Million
2022 0.92% 64.15% 0.01x 1.04x $-19.48 Million
2023 9.73% 0.00% 0.00x 1.19x $-100.15K
2024 -31.42% 0.00% 0.00x 1.33x $-6.48 Million

Industry Comparison

This section compares Target Global Acquisition I Corp's net assets metrics with peer companies in the Shell Companies industry.

Industry Context

  • Industry: Shell Companies
  • Average net assets among peers: $36,677,338
  • Average return on equity (ROE) among peers: -64.57%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Target Global Acquisition I Corp (TGAA) $15.63 Million -0.05% 0.33x $20.61 Million
Artius II Acquisition Inc. Class A Ordinary Shares (AACB) $-60.27K 0.00% 0.00x $198.37 Million
Artius II Acquisition Inc. Units (AACBU) $-60.27K 0.00% 0.00x $205.28 Million
Ares Acquisition Corporation II (AACT-UN) $931.34 Million 0.00% 0.08x $399.77 Million
AA Mission Acquisition Corp. (AAM-UN) $-559.90 Million 0.00% 0.00x $349.76 Million
Global Acquisitions Corporation (AASP) $3.80 Million -5.26% 0.34x $15.42 Million
ABV Consulting Inc (ABVN) $8.75K -623.31% 2.50x $461.96K
Atlantic Coastal Acquisition Corp II (ACAB) $-8.52 Million 0.00% 0.00x $2.44 Million
Annabidiol Corp (ACBD) $-501.57K 0.00% 0.00x $13.62K
ACRO Biomedical Co Ltd (ACBM) $685.87K -17.12% 0.46x $30.04K
Huaizhong Health Group Inc (ADAD) $-19.47K 0.00% 0.00x $3.15K